Introducing the Drug Outbreak Testing Service (DOTS) Pilot Study
The National Drug Early Warning System (NDEWS) Coordinating Center is pleased to announce the launch of the Drug Outbreak Testing Service (DOTS) pilot study. DOTS will support local experts and public health agencies experiencing a drug outbreak to identify the drug(s) behind the outbreak by providing free urinalyses of urine specimens already obtained from affected persons as part of standard treatment or administrative protocols.
Up to 20 de-identified urine specimens submitted to DOTS will be sent to an independent laboratory for testing for approximately 240 licit and illicit drugs, including synthetic opioids and other new psychoactive substances. Results will be provided in aggregate form for epidemiologic purposes only. Results are not for clinical use or legal proceedings.
Contact DOTS at: email@example.com
NDEWS is funded through a cooperative agreement from NIH/NIDA to the Center for Substance Abuse Research (CESAR) at the University of Maryland, College Park.